Von Hippel-Lindau Disease research hub

Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)

This study looks at the long-term effects of a medicine called belzutifan for people with advanced cancers or cancers linked to Von Hippel-Lindau disease. It's for those already taking belzutifan in other trials. The aim is to see how long people live after starting this treatment.